Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN113896648B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel nickel-catalyzed method for alpha beta-unsaturated amides. Reduces toxicity and cost. Reliable pharmaceutical intermediates supplier for scale-up.
Patent CN113896648B reveals nickel-catalyzed synthesis reducing toxic gas reliance and enhancing supply chain stability for pharmaceutical intermediates.
Novel nickel-catalyzed method reduces cost and toxicity for alpha beta unsaturated amide manufacturing supply chain reliability and efficiency significantly for buyers.